Market Overview

Cramer Recommends J&J For Best Big Pharma Pipeline Play

Share:
Related JNJ
A Peek Into The Markets: U.S. Stock Futures Flat; Goldman Sachs Earnings In Focus
10 Stocks To Watch For October 17, 2017
4 Dow Stocks To Report Earnings Tuesday: Investing Action Plan (Investor's Business Daily)

Coming out of the Twittersphere Wednesday afternoon: a trader asks Jim Cramer about a potential big pharma play which could fit into his or her portfolio. The trader specified the play would need to be for over the next five years. Cramer responded:

J&J (NYSE: JNJ) shares do not seem to be responding to the recommendation by Cramer, but are trading at afternoon highs. The stock is down 0.6 percent to $92.74 at last check.

Posted-In: News Jim Cramer Media Trading Ideas

 

Related Articles (JNJ)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...